tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer.
| Supplier | BOC Sciences |
|---|---|
| Product # | B1476-284927 |
| Pricing | 100 mg/unit USD $1454 |
| Cas | 571189-65-6 |
| Molecular Weight | 505.61 |
| Molecular Formula | C27H35N7O3 |
| Canonical SMILES | CC1=CC(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCN(CC4)C(=O)OC(C)(C)C)C5CCCC5 |